CareDx (NASDAQ:CDNA) Shares Down 7.9% – What's Next?
CareDx (NASDAQ:CDNA) Shares Down 7.9% – Should You Sell?
Source link
Similar Posts
CPF Savings In 2025. Top Up to MA.
If you are part of my YouTube community, you might have seen the photos I shared on my latest CPF numbers. Here they are for those who are not in the know, I was fortunate that I was able to take advantage of higher yielding T-bills to grow my CPF savings at a faster clip…
Revenge Trading — The Fastest Way to Lose Twice
😤 Revenge Trading — The Fastest Way to Lose Twice 🎯 The Lesson Every trader has been there — you take a loss, you feel that sting, and your brain whispers, “I’ll make it back right now.”That’s not strategy — that’s emotion pretending to be logic.Revenge trading is when you trade not to win, but…
GIPCL: Only 3x
Interesting that Market Cap of GIPCL is only 3x that of its operating cash flow Source: FY2025 Annual Report of Gujarat Industries Power Company Ltd Source link
Trailing Stop in Telegram Coppy (MT4/MT5): How to Set It Up Properly
Activate trailing stop Telegram Coppy for MT4 and MT5 includes 2 trailing stop modes (selected in SL trailing mode: Trail SL dynamically): Dynamic and PerTPHit. Dynamic is the classic trailing method: it starts moving the Stop Loss only after the trade reaches Trailing start (points) profit, then keeps SL at Trailing distance with updates controlled…
Biocon Biologics’ Bengaluru Unit Gets 5 US FDA Observations, Shares Up 1%
September 5, 2025September 5, 2025 Shares of Biocon Ltd rose 1% to a day’s high of Rs 364.80 on 5th September, after the company announced that the US Food and Drug Administration (FDA) had completed a routine current Good Manufacturing Practice (cGMP) inspection at Biocon Biologics’ drug substance facility…
Top Canadian Stocks to Buy With $5,000 in 2025
With 2025 now underway, investors have a significant opportunity to capitalize on shifting market conditions. Inflation has cooled significantly, and with interest rates expected to decline further, many top Canadian stocks could see renewed momentum, making now the perfect time to buy these businesses. While uncertainty still remains – particularly with geopolitical risks and lingering…
